Acumen Pharmaceuticals
ABOS
ABOS
50 hedge funds and large institutions have $278M invested in Acumen Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+3
Holders Change %
+6.38%
% of All Funds
0.86%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
15
Increased
17
Reduced
11
Closed
12
Calls
$4.07M
Puts
$503K
Net Calls
+$3.57M
Net Calls Change
+$3.65M
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
$11.2M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
$12M |
| 3 |
Millennium Management
New York
|
$4.72M |
| 4 |
PA
Perceptive Advisors
New York
|
$4.01M |
| 5 |
GPC
Guardian Point Capital
Charlottesville,
Virginia
|
$4.01M |
